Amarin Corp Plcuk (AMRN) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2025)
Amarin Corp Plcuk (AMRN) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 4.65% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 5.45% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 5.00% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 6.91% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.03% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 15.61% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.73% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.85% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 5.03% |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -76.05% |
| Sep 30, 2025 | -76.48% |
| Jun 30, 2025 | -76.91% |
| Mar 31, 2025 | -77.29% |
| Dec 31, 2024 | -77.61% |
| Sep 30, 2024 | -75.18% |
| Jun 30, 2024 | -69.42% |
| Mar 31, 2024 | -64.83% |
| Dec 31, 2023 | -61.62% |
| Sep 30, 2023 | -59.21% |
| Jun 30, 2023 | -57.40% |
| Mar 31, 2023 | -57.67% |
| Dec 31, 2022 | -28.20% |
| Sep 30, 2022 | -22.23% |
| Jun 30, 2022 | 9.84% |
| Mar 31, 2022 | 182.20% |
| Dec 31, 2021 | 182.81% |
| Sep 30, 2021 | 183.31% |
| Jun 30, 2021 | 365.34% |
| Mar 31, 2021 | 353.23% |